Results should be interpreted in the clinical and analytical context of the patient.
Diagnostic Utility of Bronchoalveolar Lavage Flow Cytometric Leukocyte Profiling in Interstitial Lung Disease and Infection
Erika M. Novoa-Bolivar, José A. Ros, Sonia Pérez-Fernández, José A. Campillo, Ruth López-Hernández, Rosana González-López, Inmaculada Ruiz-Lorente, Almudena Otálora-Alcaraz, Cristina Ortuño-Hernández, Lourdes Gimeno, Diana Ceballos-Francisco, Manuel Muro, Elena Solana-Martínez, Pablo Martínez-Camblor, Alfredo Minguela*.
Predictive Value of Flow Cytometry Quantification of BAL Lymphocytes and Neutrophils in ILD
Erika M. Novoa-Bolivar, José A. Ros, Sonia Pérez-Fernández, José A. Campillo, Ruth López-Hernández, Rosana González-López, Almudena Otálora-Alcaraz, Cristina Ortuño-Hernández, Lourdes Gimeno, Inmaculada Ruiz-Lorente, Diana Ceballos-Francisco, Manuel Muro, Elena Solana, Pablo Martínez-Camblor, Alfredo Minguela*.
| Series of cases used for the calculations in this web | |||
|---|---|---|---|
| Cell-predominant pathologies | (N) | Man (%) | Age |
| BAL-control | 112 | 53.3% | 53.5±16.6 |
| Sarcoidosis | 82 | 48.20% | 55.6±14.8 |
| Hypersensitivity pneumonitis (HP) | 48 | 49.0% | 50,4±17.6 |
| Organized cryptogenic pneumonia (COP) | 44 | 46.50% | 62.3±17.4 |
| Lymphocytic interstitial pneumonia (LIP) | 37 | 69.20% | 53.2±15.9 |
| Desquamative interstitial pneumonitis (DIP) | 35 | 52.8% | 54.4±20.8 |
| Nonspecific interstitial pneumonia (NSIP) | 156 | 48.1% | 59.3±15.5 |
| Pneumoconioses | 27 | 96.3% | 56.5±16.0 |
| Unclassifiable-ILD (U-ILD) | 80 | 60.0% | 61.3±12.4 |
| Usual interstitial pneumonia (UIP = IPF) | 145 | 71.70% | 65.8±12.3 |
| Respiratory bronchiolitis ILD (RB-ILD) | 25 | 40.0% | 53.3±22.8 |
| Acute interstitial pneumonia (AIP) | 26 | 56.0% | 57.5±21.9 |
| Pulmonary infection | 231 | 59.0% | 62.1±15.6 |
| Eosinophilic-ILD | 17 | 80.0% | 48.4±22.7 |
| Pulm. Langerhans c. histiocytosis (PLCH) | 9 | 66.7% | 36.7±15.8 |
